Erratum to: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario. [Harm Reduct J. (2017), 14, 6, (1-9)]. doi:10.1186/s12954-017-0134-5

0Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

After publication of the original article [1], it was noted that one of the author's name and affiliation was presented incorrectly. The correct name of the author (Nancy E. Lightfoot) and affiliation (2School of Rural and Northern Health, Laurentian University, 935 Ramsey Lake Rd., Sudbury, ON P3E 2C6, Canada) is published in this Erratum for quick reference. The original article was corrected. We apologise for any confusion this may have caused.

Cite

CITATION STYLE

APA

Franklyn, A. M., Eibl, J. K., Gauthier, G., Pellegrini, D., Lightfoot, N. E., & Marsh, D. C. (2017, March 28). Erratum to: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario. [Harm Reduct J. (2017), 14, 6, (1-9)]. doi:10.1186/s12954-017-0134-5. Harm Reduction Journal. BioMed Central Ltd. https://doi.org/10.1186/s12954-017-0140-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free